Design and evaluation of ocular inserts of moxifloxacin hydrochloride

International Journal of Pharmaceutical Research

Volumn 4, Issue 3, 2012, Pages 42-48

  Patil, Shrishail S ^a   Hiremath, Doddayya ^a   Reddy, Pradeep ^a   Sirse, Kranthi Kumar ^b  

^a NET Pharmacy College   (India)

^b KARNATAKA COLLEGE OF PHARMACY   (India)

Author keywords

Controlled Release; In Vitro In Vivo Studies; Moxifloxacin Hydrochloride; Ocular Inserts

Indexed keywords

ETHYL CELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; MOXIFLOXACIN; POLYMER; POVIDONE; WATER;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG INTERACTION; EXCIPIENT COMPATIBILITY; EYE IRRITATION; FOLDING ENDURANCE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OCULAR INSERT; PHYSICAL CHEMISTRY; RABBIT; SOLUBILITY; THICKNESS; WEIGHT;

EID: 84880791723     PISSN: None     EISSN: 09752366     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Gamal SSE, Naggar V, Allam AN. Formulation and evaluation of acyclovir ophthalmic inserts Asian J Pharmaceutical Sci 2008; 3(2): 58-67.
2. Patel UL, Chotai NP, Nagda CD, Patel KN, Patel MP. Preparation and evaluation of ocular inserts for controlled delivery of gatifloxacin sesquehydrate. Indian J Pharm Sci 2009; 1(2): 342-52.
3. Anumolu SS, Singh Y, Gao D, Stein S, Sinko JP. Design and evaluation of novel fast forming pilocarpine-loaded ocular hydrogels for sustained pharmacological response. J Control Release 2009; 137: 152-9.
4. Barry A. Schlech, Eduardo Alfonso. Overview of the potency of moxifloxacin ophthalmic solution 0.5% (vigamox). J Surv ophthal 2005; 50(1): S7-15.
5. Moxifloxacin. Tuberculosis 2008; 88(2): 127-131.
6. Misra M, Misra AK, Zope P, Panpalia GM, Dorle AK. Simple and validated uv-spectroscopic method for estimation of moxifloxacin HCl in bulk and formulation. JGPT 2010; 2(6): 21-27.
7. Rathore KS, Nema RK. Review on ocular inserts. Int J PharmTech Res 2009;1(2): 164-69.
8. Sankar V, Chandrasekaran AK, Durga S, Geetha G, Ravichandran V, Vijayakumar A, Raguraman S and G. Geetha. Design and evaluation of diclofenac sodium ophthalmic inserts. Acta Pharmaceutica Sciencia. 2006; 48: 5-10.
9. Mishra DN, Gilhotra RM. Design and characterization of bioadhesive in-situ gelling ocular inserts of gatifloxacin sesquihydrate. DARU 2008; 16(1): 1-8.
10. Patel UL, Chotai NP, Nagda CD, Patel KN, Patel MP. Preparation and evaluation of ocular inserts for controlled delivery of gatifloxacin sesquehydrate. Indian J Pharm Sci 2009; 1(2): 342-52.
11. Dipti PH, Manish PP, Madhabhai MP. Formulation and evaluation of drug free ophthalmic films prepared by using various synthetic polymers. J Young Pharm. 2009; 1(2): 116-20.
12. Patel U L, Chotai NP, Nagda CD, Patel MP, Patel KN. Formulation and in vitro evaluation of moxifloxacin hydrochloride ophthalmic inserts. International Journal of Pharmaceutical Research. 2009; 1(1): 23-30.
13. Sreenivas SA, Hiremath SP, Godbole AM. Ofloxacin ocular inserts: design, formulation and evaluation. IJPT 2006; 5(2): 159-62.
14. Kawarkhe S, Poddar SS. Design of mucoadhesive vaginal metronidazole films. Acta Pharmaceutica Sciencia. 2010; 52: 181-89.
15. Deepak S, Rana AC. Formulation development of quetiapine fumarate sr matrix tablets. Der Pharmacia Sinica 2010; 1(1): 48-57.